Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03849222
Other study ID # REC 61
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date August 20, 2013
Est. completion date September 1, 2016

Study information

Verified date February 2019
Source Al-Azhar University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was conducted to evaluate the effect of the use of apical matrix, with Mineral Trioxide Aggregate (MTA) or calcium hydroxide Ca(OH)2 Apexification on apical healing and calcific barrier formation of immature teeth with non- vital pulp.


Description:

Conventional root canal filling procedures are challenging in cases of teeth with necrotic pulp, immature apices, and periapical lesions because of the absence of natural apical constriction and the presence of moisture contamination. In these cases, the risk of extrusion of the root filling materials and the difficulty in managing apical seals compromise the long-term outcome of treatment.

Management of immature teeth with non-vital pulp were confined to custom fitting the filling material, paste fills and apical surgery. The limited success enjoyed by these procedures resulted in significant interest in the phenomenon of establishment of an apical barrier like apexification or continued apical development. Apexification defined as a procedure to induce a calcified barrier in a root with an open apex and necrotic pulp Traditionally, the most commonly used material for apexification is Ca(OH)2 .Despite the high success rate of The long-term Ca(OH)2 apexification , there are several disadvantages to this technique; Length of time for induction of apical hard tissue barriers. Incomplete apical hard tissue barriers because of vascular inclusions.To avoid the challenges associated with long-term Ca(OH)2 apexification procedures, a non-surgical, one-step apexification using MTA as apical plug.

The major problem in cases of a wide open apex is the need to limit the apexification material at the apex, thus avoiding the extrusion of a large amount of material into the periodontal tissue. The use of a matrix is advisable since its placement in the area of bone destruction provides a base on which the sealing material can be packed .

This randomized controlled trial study was carried out to compare the clinical and radiographic outcome of Ca(OH)2 and MTA with or without internal matrix in non-vital immature maxillary incisors.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date September 1, 2016
Est. primary completion date April 20, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 8 Years to 16 Years
Eligibility Inclusion Criteria:

- Immature permanent maxillary anterior teeth

- Non vital pulp

- 6-18 years old

- Half or more root length developed Restorable

- No internal or external root resorption

- No horizontal or vertical root fractures

- Fit and healthy patient

Exclusion Criteria:

- Mature

- Vital pulp

- <6 ,>18 years old

- Less than half of the root developed

- Non - restorable

- Root resorption

- Horizontal or vertical root fractures

- Patients with history of uncontrolled diabetes, immunosuppression, severe asthma Patients suffering from periodontal disease

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Apexification

Drug:
MTA

Ca(OH)2

Apical matrix
collagen membrane (Biocollagen; Bioteck:Turin, Italy)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Al-Azhar University

Outcome

Type Measure Description Time frame Safety issue
Primary Change in pain on percussion Assessed by tapping the tooth with the back of the mirror (Present or absent) binary outcome baseline, 3 months, 6 months, and 12 months
Primary Change in swelling and/or sinus Assessed by visual examination of labial vestibule.The presence of swelling or sinus reported by a binary question yes/no baseline, 3 months, 6 months, and 12 months
Primary Change in periapical pathosis Change in periapical bone density on follow up radiographs to assess the healing process 12 months
Secondary presence of a calcified apical barrier or not Teeth will be reviewed clinically and radiographically in order to detect the calcific barrier formation 3, 6 and 12 months
Secondary Periapical Lesion scored with periapical index ( PAI) Radio graphically The periapical index provides an ordinal scale of 5 scores ranging from ''healthy'' to ''severe periodontitis with exacerbating features''. (1) Normal periapical structures. (2) Small changes in bone structure. (3) Changes in bone structure with some diffuse mineral loss.(4) Periodontitis with well-de?ned radiolucent area. (5) Severe periodontitis with exacerbating features. (1, 2: healthy and 3, 4, 5: pathological).baseline, 3 months, 6 months, and 12 months 12 months
See also
  Status Clinical Trial Phase
Completed NCT01976065 - Regeneration of Pulp-Dentin Development in Teeth With Necrotic Pulps and Immature Roots Phase 1
Active, not recruiting NCT03763110 - Photo-Activated Disinfection Versus Triple-Antibiotic Paste for Management of Necrotic Young Permanent Anterior Teeth N/A
Completed NCT00881907 - Tissue Characterization in Teeth Treated With a Regeneration Protocol Phase 0
Recruiting NCT04313010 - Effectiveness of Regenerative Endodontics Therapy for Single-rooted Mature Permanent Tooth With Pulp Necrosis N/A
Not yet recruiting NCT03813433 - Discoloration of Endosequence and Mineral Trioxde Aggregate in Revascularization of Necrotic Immature Permanent Teeth N/A
Completed NCT03589560 - Evaluation of Biodentine and Mineral Trioxide Aggregate in Revascularization of Non Vital Immature Anterior Teeth N/A
Not yet recruiting NCT03717337 - Success Rate of Single Versus Two Visit Regenerative Treatment Protocol in Non Vital Mature Anterior Teeth N/A
Completed NCT01817413 - Comparison of Two Dental Techniques Used to Treat Teeth Which Have Become Infected or Painful Following Trauma Phase 4
Completed NCT00881491 - Treatment Outcome With a Revascularization Protocol Using the Triple Versus Double Antibiotic Paste Phase 0